Brown Advisory Inc Karuna Therapeutics, Inc. Transaction History

Brown Advisory Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$161.01 - $317.85 $1.78 Million - $3.52 Million	11,059 Added 3.43%	333,144 $105 Million
Q3 2023 Oct 24, 2023	SELL	$164.66 - $218.08 $226,078 - $299,423	-1,373 Reduced 0.42%	322,085 $54.5 Million
Q2 2023 Jul 31, 2023	BUY	$176.32 - $240.22 $69,999 - $95,367	397 Added 0.12%	323,458 $70.1 Million
Q1 2023 May 08, 2023	BUY	$161.33 - $204.36 $10.2 Million - $13 Million	63,499 Added 24.46%	323,061 $58.7 Million
Q4 2022 Feb 13, 2023	BUY	$191.53 - $236.82 $5.68 Million - $7.02 Million	29,649 Added 12.9%	259,562 $51 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $28.5 Million - $63.8 Million	229,913 New	229,913 $51.7 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.